Active	Status	Sponsor type	Region	Phase	Filter
6 Active 0 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Shiu, Michael
NCT06176170: VividWhite Glaucoma Implant (VW-51) Pivotal Study	Recruiting	N/A	65	RoW	VividWhite Glaucoma Implant (VW-51)	VividWhite Pty Ltd	Glaucoma	12/25	12/25
Coote, Michael
NCT05160805: A Phase 1b Study of ONL1204 Ophthalmic Solution in Patients With Progressing Open Angle Glaucoma	Active, not recruiting	1b	25	RoW	ONL1204 Ophthalmic solution (Dose A), ONL1204 Ophthalmic solution (Dose B), Sham procedure	ONL Therapeutics	Open Angle Glaucoma	04/24	10/24
NCT04060758: Open Label, Sequential-dose Study of PA5108 Latanoprost FA SR Ocular Implant for Mild-moderate Glaucoma	Active, not recruiting	1	37	RoW	PA5108 Latanoprost FA SR Ocular Implant, PA5108	PolyActiva Pty Ltd	Open Angle Glaucoma	09/24	02/25
NCT05441930: A Study of Levofloxacin Ocular Implant in Patients Undergoing Routine Bilateral Cataract Surgery	Withdrawn	1	12	US, RoW	Levofloxacin Ocular Implant, Control	PolyActiva Pty Ltd	Cataract	12/23	03/24
NCT06176170: VividWhite Glaucoma Implant (VW-51) Pivotal Study	Recruiting	N/A	65	RoW	VividWhite Glaucoma Implant (VW-51)	VividWhite Pty Ltd	Glaucoma	12/25	12/25
Healey, Danielle
NCT05160805: A Phase 1b Study of ONL1204 Ophthalmic Solution in Patients With Progressing Open Angle Glaucoma	Active, not recruiting	1b	25	RoW	ONL1204 Ophthalmic solution (Dose A), ONL1204 Ophthalmic solution (Dose B), Sham procedure	ONL Therapeutics	Open Angle Glaucoma	04/24	10/24